LncRNA-mRNA Co-Expression Analysis Identifies AL133346.1/CCN2 as Biomarkers in Pediatric B-Cell Acute Lymphoblastic Leukemia.

AL133346.1 CCN2 CTGF biomarker lncRNA expression pediatric B-ALL

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
17 Dec 2020
Historique:
received: 02 11 2020
revised: 10 12 2020
accepted: 15 12 2020
entrez: 22 12 2020
pubmed: 23 12 2020
medline: 23 12 2020
Statut: epublish

Résumé

Pediatric acute B-cell lymphoblastic leukemia (B-ALL) constitutes a heterogeneous and aggressive neoplasia in which new targeted therapies are required. Long non-coding RNAs have recently emerged as promising disease-specific biomarkers for the clinic. Here, we identified pediatric B-ALL-specific lncRNAs and associated mRNAs by comparing the transcriptomic signatures of tumoral and non-tumoral samples. We identified 48 lncRNAs that were differentially expressed between pediatric B-ALL and healthy bone marrow samples. The most relevant lncRNA/mRNA pair was AL133346.1/CCN2 (previously known as RP11-69I8.3/CTGF), whose expression was positively correlated and increased in B-ALL samples. Their differential expression pattern and their strong correlation were validated in external B-ALL datasets (Therapeutically Applicable Research to Generate Effective Treatments, Cancer Cell Line Encyclopedia). Survival curve analysis demonstrated that patients with "high" expression levels of CCN2 had higher overall survival than those with "low" levels (

Identifiants

pubmed: 33348573
pii: cancers12123803
doi: 10.3390/cancers12123803
pmc: PMC7765782
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Spanish Ministry of Economy and Business
ID : SAF2015-67919-R
Organisme : Consejería de Salud de la Junta de Andalucía
ID : Pl-0245-2017; CS2016-3
Organisme : Asociación Española Contra el Cáncer (AECC) Foundation
ID : LabAECC-2018
Organisme : Programa Operativo FEDER 2018
ID : B-CTS-126-UGR18
Organisme : Fundación Benéfica Anticáncer Santa Cándida y San Francisco Javier
ID : Predoctoral Fellowship
Organisme : Spanish Ministry of Education, Culture and Sports FPU Felowship
ID : FPU17/00067; FPU17/01258
Organisme : La Caixa Foundation Fellowship
ID : LCF/BQ/DE15/10360019
Organisme : Marie Sklodowska Curie Actions Postdoctoral Fellowship
ID : H2020-MSCA-IF-2018
Organisme : Aula de Investigación sobre la Leucemia infantil: Héroes contra la Leucemia
ID : Aula2020

Références

Cell Cycle. 2008 Aug 15;7(16):2485-92
pubmed: 18719380
Cancer Manag Res. 2020 Oct 15;12:10181-10198
pubmed: 33116873
Leuk Lymphoma. 2020 Oct 15;:1-10
pubmed: 33054480
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820965580
pubmed: 33073700
Mol Cancer Res. 2015 May;13(5):839-51
pubmed: 25681502
Ther Adv Hematol. 2020 Jun 2;11:2040620720927575
pubmed: 32537116
N Engl J Med. 2008 Nov 27;359(22):2313-23
pubmed: 19038878
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Cell Mol Life Sci. 2018 Feb;75(3):417-446
pubmed: 28819864
Gene. 2019 Jul 30;707:172-177
pubmed: 30943439
Nat Med. 2015 Nov;21(11):1253-61
pubmed: 26540387
Blood Cancer J. 2017 Jun 30;7(6):e577
pubmed: 28665419
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Cancer Metastasis Rev. 2020 Mar;39(1):161-171
pubmed: 31902036
Genome Biol. 2017 Oct 31;18(1):206
pubmed: 29084573
Oncotarget. 2016 Nov 8;7(45):73769-73780
pubmed: 27650541
Database (Oxford). 2017 Jan 1;2017:
pubmed: 28605766
J Cell Commun Signal. 2015 Sep;9(3):267-78
pubmed: 26026820
Nat Commun. 2020 Jun 25;11(1):3214
pubmed: 32587247
Mol Cell. 2016 Apr 7;62(1):104-10
pubmed: 27041223
Blood. 2008 Oct 15;112(8):3425-33
pubmed: 18544678
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Blood. 2010 Feb 18;115(7):1394-405
pubmed: 19880498
Commun Biol. 2020 Feb 5;3(1):56
pubmed: 32024996
Genes (Basel). 2020 Mar 13;11(3):
pubmed: 32183133
Blood Cancer J. 2019 Nov 25;9(12):93
pubmed: 31767830
Cell Physiol Biochem. 2018;47(3):893-913
pubmed: 29843138
Aging (Albany NY). 2020 Oct 4;12(19):18970-18981
pubmed: 33012724
Am J Blood Res. 2018 Dec 10;8(4):29-56
pubmed: 30697448
Cell. 2009 Feb 20;136(4):629-41
pubmed: 19239885
Cell. 2018 Jan 25;172(3):393-407
pubmed: 29373828
Int J Mol Sci. 2019 Jun 15;20(12):
pubmed: 31208040
Oncotarget. 2017 Jan 31;8(5):7477-7488
pubmed: 27980230
Nat Commun. 2019 Apr 3;10(1):1519
pubmed: 30944321
Nature. 2010 Sep 2;467(7311):86-90
pubmed: 20693987
Oncogene. 2010 Mar 18;29(11):1580-7
pubmed: 19966857
J Cell Commun Signal. 2013 Aug;7(3):169-77
pubmed: 23420091
Cancer Cell. 2016 Apr 11;29(4):452-463
pubmed: 27070700
PLoS One. 2018 May 1;13(5):e0196681
pubmed: 29715309
Oncotarget. 2016 Sep 27;7(39):64148-64167
pubmed: 27580177

Auteurs

Marta Cuadros (M)

Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Av. de la Investigación 11, 18016 Granada, Spain.
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria (ibs. Granada), Av. Fuerzas Armadas 2, 18014 Granada, Spain.

Daniel J García (DJ)

Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Av. de la Investigación 11, 18016 Granada, Spain.
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.

Alvaro Andrades (A)

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria (ibs. Granada), Av. Fuerzas Armadas 2, 18014 Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Av. de Fuente Nueva S/N, 18071 Granada, Spain.

Alberto M Arenas (AM)

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Av. de Fuente Nueva S/N, 18071 Granada, Spain.

Isabel F Coira (IF)

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Av. de Fuente Nueva S/N, 18071 Granada, Spain.

Carlos Baliñas-Gavira (C)

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria (ibs. Granada), Av. Fuerzas Armadas 2, 18014 Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Av. de Fuente Nueva S/N, 18071 Granada, Spain.

Paola Peinado (P)

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria (ibs. Granada), Av. Fuerzas Armadas 2, 18014 Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Av. de Fuente Nueva S/N, 18071 Granada, Spain.

María I Rodríguez (MI)

Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Av. de la Investigación 11, 18016 Granada, Spain.
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria (ibs. Granada), Av. Fuerzas Armadas 2, 18014 Granada, Spain.

Juan Carlos Álvarez-Pérez (JC)

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria (ibs. Granada), Av. Fuerzas Armadas 2, 18014 Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Av. de Fuente Nueva S/N, 18071 Granada, Spain.

Francisco Ruiz-Cabello (F)

Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Av. de la Investigación 11, 18016 Granada, Spain.
Department of Clinical Analysis and Immunology, UGC Laboratorio Clínico, University Hospital Virgen de las Nieves, 18014 Granada, Spain.

Mireia Camós (M)

Hematology Laboratory, Institut de Recerca Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, 28029 Madrid, Spain.
Leukemia and Other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, 08950 Barcelona, Spain.

Antonio Jiménez-Velasco (A)

Hematology Laboratory, Universitary Regional Hospital, Av. de Carlos Haya, 29010 Málaga, Spain.

Pedro P Medina (PP)

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av. de la Ilustración 114, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria (ibs. Granada), Av. Fuerzas Armadas 2, 18014 Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Av. de Fuente Nueva S/N, 18071 Granada, Spain.

Classifications MeSH